drugset / Trial / NCT05473624
Study of HRS-1167 as Monotherapy in Patients With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
This study is designed to determine if treatment with HRS-1167 alone is safe, tolerable, and has anti-cancer activity in patients with advanced solid tumors.
Timeline
- Start
- 2022-08-23
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS-1167 | Unknown | — | — |